Our news
-
SITU announces a trio of new trials
18 June 2024
-
ODD SOCKS Opens to Recruitment
30 May 2024
-
WHITE-13 DECI Trial now open to recruitment
28 May 2024
-
The UNDER Study opens to recruitment
12 April 2024
-
WISE study opens to recruitment
15 January 2024
Our training sessions
-
-
-
-
Oxford BRC Stats Hub Lunchtime Seminar Series: What's a Clinical Trial?
Wednesday, 04 September 2024, 1pm to 1.30pm
Our recent publications
-
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy
Hamdy FC. et al, (2024), European journal of nuclear medicine and molecular imaging
-
Early versus delayed weight-bearing following operatively treated ankle fracture (WAX): a non-inferiority, multicentre, randomised controlled trial.
Bretherton CP. et al, (2024), Lancet
-
A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301).
Spiliopoulou P. et al, (2024), J exp clin cancer res, 43
-
Cost-effectiveness analysis of a pragmatic randomized trial evaluating surgical reconstruction versus rehabilitation in patients with long-standing anterior cruciate ligament injury.
Leal J. et al, (2024), Bone joint j, 106-B, 38 - 45
-
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Abhishek A. et al, (2024), Lancet rheumatol, 6, e92 - e104
Collaborate with us!
We are open for collaborations and welcome your requests at any point.
NIHR CTU SUPPORT
This unit receives National Institute for Health Research CTU Support Funding.
This funding has been awarded to support the unit in developing and supporting NIHR trials.